Cover Image

Correction: Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.

[This corrects the article DOI: 10.1371/journal.pntd.0003557.].

Saved in:

Bibliographic Details
Main Authors:	Rajendra K Baharia (Author), Rati Tandon (Author), Tanuj Sharma (Author), Manish K Suthar (Author), Sanchita Das (Author), Mohammad Imran Siddiqi (Author), Jitendra Kumar Saxena (Author), Shyam Sundar (Author), Anuradha Dube (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2015-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.
by: Rajendra K Baharia, et al.
Published: (2015)

Over-expression of 60s ribosomal L23a is associated with cellular proliferation in SAG resistant clinical isolates of Leishmania donovani.
by: Sanchita Das, et al.
Published: (2013)

Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani.
by: Sanchita Das, et al.
Published: (2015)

The mitochondrial SIR2 related protein 2 (SIR2RP2) impacts Leishmania donovani growth and infectivity.
by: Nimisha Mittal, et al.
Published: (2017)

Latent infection with Leishmania donovani in highly endemic villages in Bihar, India.
by: Epco Hasker, et al.
Published: (2013)

Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani.
by: Ayako Morimoto, et al.
Published: (2016)

Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study.
by: Kamlesh Gidwani, et al.
Published: (2011)

Leishmania donovani develops resistance to drug combinations.
by: Raquel García-Hernández, et al.
Published: (2012)

Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.
by: Bart Ostyn, et al.
Published: (2011)

Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection.
by: Sandip Mukherjee, et al.
Published: (2012)

Fitness of Leishmania donovani parasites resistant to drug combinations.
by: Raquel García-Hernández, et al.
Published: (2015)

Livestock and rodents within an endemic focus of Visceral Leishmaniasis are not reservoir hosts for Leishmania donovani.
by: Anurag Kumar Kushwaha, et al.
Published: (2022)

In vitro activity and mode of action of phenolic compounds on Leishmania donovani.
by: Christine Achiaa Antwi, et al.
Published: (2019)

Sphingosine-1-phosphate signaling in Leishmania donovani infection in macrophages.
by: Mohd Arish, et al.
Published: (2018)

Metabolic variation during development in culture of Leishmania donovani promastigotes.
by: Ana Marta Silva, et al.
Published: (2011)

Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress.
by: Deepak Kumar Deep, et al.
Published: (2017)

Hemophagocytosis induced by Leishmania donovani infection is beneficial to parasite survival within macrophages.
by: Ayako Morimoto, et al.
Published: (2019)

Infecção experimental de Calomys callosus (Rodentia-Cricetidae) com Leishmania donovani chagasi (Laison, 1982) Experimental infection of Calomys callosus (Rodentia-Cricetidae) with Leishmania donovani
by: Dalva A. Mello, et al.
Published: (1984)

Leishmania donovani argininosuccinate synthase is an active enzyme associated with parasite pathogenesis.
by: Ines Lakhal-Naouar, et al.
Published: (2012)

Polymorphism in the HASPB repeat region of East African Leishmania donovani strains.
by: Arie Zackay, et al.
Published: (2013)

Inhibiting <i>Leishmania donovani</i> Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling
by: Patrick O. Sakyi, et al.
Published: (2023)

Spectrum of Leishmania donovani infection in the Southwest of Sudan: A rapid epidemiological mapping
by: Sharief AH, et al.
Published: (2019)

Correction: Latent Infection with Leishmania donovani in Highly Endemic Villages in Bihar, India
Published: (2013)

Single locus genotyping to track Leishmania donovani in the Indian subcontinent: Application in Nepal.
by: Keshav Rai, et al.
Published: (2017)

Targeting Ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylase.
by: Laura-Isobel McCall, et al.
Published: (2015)

Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles
by: Alessio Nocentini, et al.
Published: (2018)

Homology modeling of Leishmania donovani enolase and its molecular interaction with novel inhibitors
by: Jay Prakash Mahato, et al.
Published: (2017)

Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune response.
by: Rajan Guha, et al.
Published: (2014)

Evaluation of Modulators of cAMP-Response in Terms of Their Impact on Cell Cycle and Mitochondrial Activity of Leishmania donovani
by: Amrita Saha, et al.
Published: (2020)

Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo.
by: Farhat Afrin, et al.
Published: (2019)

Genomic analysis of natural intra-specific hybrids among Ethiopian isolates of Leishmania donovani.
by: James A Cotton, et al.
Published: (2020)

Elucidating the possible mechanism of action of some pathogen box compounds against Leishmania donovani.
by: Wandayi Emmanuel Amlabu, et al.
Published: (2020)

Multifaceted population structure and reproductive strategy in Leishmania donovani complex in one Sudanese village.
by: Virginie Rougeron, et al.
Published: (2011)

Induced pluripotent stem cell-derived human macrophages as an infection model for Leishmania donovani.
by: Lore Baert, et al.
Published: (2024)

Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
by: Tadele M, et al.
Published: (2020)

Antifungal compounds from Streptomyces associated with attine ants also inhibit Leishmania donovani.
by: Humberto E Ortega, et al.
Published: (2019)

Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts.
by: Bart Ostyn, et al.
Published: (2015)

Genetic Manipulation of Leishmania donovani to Explore the Involvement of Argininosuccinate Synthase in Oxidative Stress Management.
by: Abul Hasan Sardar, et al.
Published: (2016)

PCR for detection of Leishmania donovani from microscopically negative tissue smears of suspected patients in Gondar, Ethiopia.
by: Roma Melkamu, et al.
Published: (2023)

New insights into experimental visceral leishmaniasis: Real-time in vivo imaging of Leishmania donovani virulence.
by: Guilherme D Melo, et al.
Published: (2017)